Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of the Use of "de Novo" Everolimus for the Expression of Cytokines in Kidneys From Extended Criteria Donors and With Delayed Graft Function

NCT01663805 is registered in ClinicalTrials.gov with MARIO ABBUD FILHO as lead sponsor.

NCT NCT01663805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01663805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of the Use of "de Novo" Everolimus for the Expression of Cytokines in Kidneys From Extended Criteria Donors and With Delayed Graft Function
Lead sponsor
MARIO ABBUD FILHO
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2012
Completion date
June 30, 2015
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

delayed function of renal transplant